| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
KURA
Kura Oncology
|
Jun 04, 2026 | BUY |
Strong Buy
+133.7% avg upside
26 analysts
|
$23.00
107.15% Upside
|
+18.1% |
|
ALGS
Aligos Therapeutics
|
Jun 01, 2026 | BUY |
Strong Buy
+724.6% avg upside
11 analysts
|
$45.00
704.93% Upside
|
· |
|
VKTX
Viking Therapeutics
|
May 28, 2026 | BUY |
Strong Buy
+92.1% avg upside
31 analysts
|
$89.00
137.69% Upside
|
+16.4% |
|
RANI
Rani Therapeutics Holdings
|
May 18, 2026 | BUY |
Strong Buy
+1131.7% avg upside
10 analysts
|
$9.00
1066.91% Upside
|
-23.7% |
|
PIII
P3 Health Partners
|
May 15, 2026 | BUY |
Buy
+1665.2% avg upside
8 analysts
|
$962.00
8360.86% Upside
|
+8.3% |
|
LITS
Lite Strategy
|
Sep 02, 2015 | BUY |
Buy
+1045.8% avg upside
13 analysts
|
$7.00
636.63% Upside
|
· |
|
IMNN
Imunon
|
Aug 10, 2015 | BUY |
Strong Buy
+667.9% avg upside
11 analysts
|
$7.00
266.43% Upside
|
-44.4% |
|
TSE:BHC
Bausch Health Companies
|
Dec 30, 2014 | BUY |
Buy
+761.0% avg upside
29 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.